{
    "ABCC2": {
        "expression": [
            {
                "Organ": "Brain",
                "Source": "Nishimura",
                "Relative Expression": 0.000408
            },
            {
                "Organ": "Kidney*",
                "Source": "Nishimura",
                "Relative Expression": 0.0751
            },
            {
                "Organ": "Liver*",
                "Source": "Nishimura",
                "Relative Expression": 0.208
            },
            {
                "Organ": "Placenta*",
                "Source": "Nishimura",
                "Relative Expression": 0.00311
            },
            {
                "Organ": "Small Intestine*",
                "Source": "Nishimura",
                "Relative Expression": 0.0273
            },
            {
                "Organ": "Kidney*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": 0.337
            },
            {
                "Organ": "Liver*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": 6.815
            }
        ],
        "inhibitors": [
            {
                "Inhibitor": "Curcumin",
                "IC50 (μM)": "5",
                "Ki (μM)": null,
                "Substrate used": "Ethacrynic acid glutathione",
                "Cell System": "MRP2-expressing Sf9 vesicles",
                "Reference": "Wortelboer, 2003"
            },
            {
                "Inhibitor": "Cyclosporine",
                "IC50 (μM)": "10",
                "Ki (μM)": null,
                "Substrate used": "Calcein AM",
                "Cell System": "MDCK II-MRP2",
                "Reference": "Wortelboer, 2003"
            },
            {
                "Inhibitor": "Cyclosporine",
                "IC50 (μM)": null,
                "Ki (μM)": 4.7,
                "Substrate used": "Leukotriene C4",
                "Cell System": "MRP2-expressing LLC-PK1 vesicles",
                "Reference": "Chen, 1999"
            },
            {
                "Inhibitor": "Cyclosporine",
                "IC50 (μM)": null,
                "Ki (μM)": 8.11,
                "Substrate used": "Vinblastine",
                "Cell System": "MDCK II-MRP2",
                "Reference": "Tang, 2002"
            },
            {
                "Inhibitor": "Daunorubicin",
                "IC50 (μM)": null,
                "Ki (μM)": 49.4,
                "Substrate used": "Vinblastine",
                "Cell System": "MDCK II-MRP2",
                "Reference": "Tang, 2002"
            },
            {
                "Inhibitor": "Delavirdine",
                "IC50 (μM)": "ND",
                "Ki (μM)": null,
                "Substrate used": "CMFDA",
                "Cell System": "MDCKII-MRP2",
                "Reference": "Weiss, 2007"
            },
            {
                "Inhibitor": "Efavirenz",
                "IC50 (μM)": "ND",
                "Ki (μM)": null,
                "Substrate used": "CMFDA",
                "Cell System": "MDCKII-MRP2",
                "Reference": "Weiss, 2007"
            },
            {
                "Inhibitor": "Emtricitabine",
                "IC50 (μM)": "ND",
                "Ki (μM)": null,
                "Substrate used": "CMFDA",
                "Cell System": "MDCKII-MRP2",
                "Reference": "Weiss, 2007"
            },
            {
                "Inhibitor": "Etoposide",
                "IC50 (μM)": null,
                "Ki (μM)": 756.0,
                "Substrate used": "Vinblastine",
                "Cell System": "MDCK II-MRP2",
                "Reference": "Tang, 2002"
            },
            {
                "Inhibitor": "Gemifloxacin",
                "IC50 (μM)": "16",
                "Ki (μM)": null,
                "Substrate used": "Erythromycin",
                "Cell System": "MDCKII-MRP2",
                "Reference": "Vadlapatla, 2011"
            },
            {
                "Inhibitor": "Indomethacin",
                "IC50 (μM)": "0.06",
                "Ki (μM)": null,
                "Substrate used": "Methotrexate",
                "Cell System": "MRP2-expressing HEK293 vesicles",
                "Reference": "El-Sheikh, 2007"
            },
            {
                "Inhibitor": "Ketoprofen",
                "IC50 (μM)": "1.4",
                "Ki (μM)": null,
                "Substrate used": "Methotrexate",
                "Cell System": "MRP2-expressing HEK293 vesicles",
                "Reference": "El-Sheikh, 2007"
            },
            {
                "Inhibitor": "MK-571",
                "IC50 (μM)": "4",
                "Ki (μM)": null,
                "Substrate used": "Ethacrynic acid glutathione",
                "Cell System": "MRP2-expressing Sf9 vesicles",
                "Reference": "Yamazaki, 2005"
            },
            {
                "Inhibitor": "MK-571",
                "IC50 (μM)": "50.0",
                "Ki (μM)": null,
                "Substrate used": "Irinotecan",
                "Cell System": "Caco-2",
                "Reference": "Luo, 2002"
            },
            {
                "Inhibitor": "MK-571",
                "IC50 (μM)": null,
                "Ki (μM)": 13.1,
                "Substrate used": "Leukotriene C4",
                "Cell System": "MRP2-expressing LLC-PK1 vesicles",
                "Reference": "Chen, 1999"
            },
            {
                "Inhibitor": "MK-571",
                "IC50 (μM)": null,
                "Ki (μM)": 26.4,
                "Substrate used": "Vinblastine",
                "Cell System": "MDCK II-MRP2",
                "Reference": "Tang, 2002"
            },
            {
                "Inhibitor": "PAK-104P",
                "IC50 (μM)": null,
                "Ki (μM)": 3.7,
                "Substrate used": "Leukotriene C4",
                "Cell System": "MRP2-expressing LLC-PK1 vesicles",
                "Reference": "Chen, 1999"
            },
            {
                "Inhibitor": "Reserpine",
                "IC50 (μM)": null,
                "Ki (μM)": 295.0,
                "Substrate used": "Vinblastine",
                "Cell System": "MDCK II-MRP2",
                "Reference": "Tang, 2002"
            },
            {
                "Inhibitor": "Valsopodar (PSC-833)",
                "IC50 (μM)": null,
                "Ki (μM)": 28.9,
                "Substrate used": "Leukotriene C4",
                "Cell System": "MRP2-expressing LLC-PK1 vesicles",
                "Reference": "Chen, 1999"
            },
            {
                "Inhibitor": "Vincristine",
                "IC50 (μM)": null,
                "Ki (μM)": 802.0,
                "Substrate used": "Vinblastine",
                "Cell System": "MDCK II-MRP2",
                "Reference": "Tang, 2002"
            }
        ],
        "substrates": [
            {
                "Substrate": "Dehydroepiandrosterone sulfate",
                "Km (μM)": 14.9,
                "Cell System": "MRP2-expressing LLC-PK1 vesicles",
                "Reference": "Yamada, 2007"
            },
            {
                "Substrate": "Estradiol-17beta-glucuronide",
                "Km (μM)": 7.2,
                "Cell System": "MRP2-expressing HEK293 vesicles",
                "Reference": "Cui, 1999"
            },
            {
                "Substrate": "Etoposide",
                "Km (μM)": 617.0,
                "Cell System": "MDCK II-MRP2",
                "Reference": "Guo, 2002"
            },
            {
                "Substrate": "Irinotecan",
                "Km (μM)": 48.9,
                "Cell System": "bile canalicular membrane vesicles",
                "Reference": "Chu, 1998"
            },
            {
                "Substrate": "Irinotecan",
                "Km (μM)": 90.8,
                "Cell System": "MDCK II-MRP2",
                "Reference": "Luo, 2002"
            },
            {
                "Substrate": "Methotrexate",
                "Km (μM)": 480.0,
                "Cell System": "MRP2-expressing HEK293 vesicles",
                "Reference": "El-Sheikh, 2007"
            },
            {
                "Substrate": "Olmesartan",
                "Km (μM)": 14.9,
                "Cell System": "MRP2-expressing LLC-PK1 vesicles",
                "Reference": "Yamada, 2007"
            },
            {
                "Substrate": "Para-aminohippurate",
                "Km (μM)": 880.0,
                "Cell System": "MRP2-expressing HEK293 vesicles",
                "Reference": "Leier, 2000"
            },
            {
                "Substrate": "Para-aminohippurate",
                "Km (μM)": 2100.0,
                "Cell System": "MRP2-expressing MDCK II vesicles",
                "Reference": "Smeets, 2004"
            },
            {
                "Substrate": "Para-aminohippurate",
                "Km (μM)": 5000.0,
                "Cell System": "MRP2-expressing Sf9 vesicles",
                "Reference": "Smeets, 2004"
            },
            {
                "Substrate": "SN-38",
                "Km (μM)": 180.0,
                "Cell System": "bile canalicular membrane vesicles",
                "Reference": "Chu, 1998"
            },
            {
                "Substrate": "SN-38 glucuronide",
                "Km (μM)": 5.7,
                "Cell System": "bile canalicular membrane vesicles",
                "Reference": "Chu, 1998"
            },
            {
                "Substrate": "Valsartan",
                "Km (μM)": 30.4,
                "Cell System": "MRP2-expressing LLC-PK1 vesicles",
                "Reference": "Yamashiro, 2006"
            },
            {
                "Substrate": "Vinblastine",
                "Km (μM)": 137.3,
                "Cell System": "MDCK II-MRP2",
                "Reference": "Tang, 2002"
            }
        ],
        "ddi": [
            {
                "DDI": "1",
                "Implicated Transporter": "MRPs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Cefmetazole",
                "AUC": "1.6",
                "Cmax": "NS",
                "CLR": "0.6",
                "CL/F": "0.6",
                "t1/2": "1.5",
                "Effect on PD": "ND",
                "Reference": "Ko, 1989",
                "More Details": "DDI 1"
            },
            {
                "DDI": "2",
                "Implicated Transporter": "OATs/MRPs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Ciprofloxacin",
                "AUC": "1.7",
                "Cmax": "NS",
                "CLR": "0.4",
                "CL/F": "0.6",
                "t1/2": "1.5",
                "Effect on PD": "ND",
                "Reference": "Jaehde, 1995",
                "More Details": "DDI 2"
            },
            {
                "DDI": "3",
                "Implicated Transporter": "OATs/MRPs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Furosemide",
                "AUC": "2.7",
                "Cmax": "1.5",
                "CLR": "0.3",
                "CL/F": "0.4",
                "t1/2": "1.7",
                "Effect on PD": "ND",
                "Reference": "Vree, 1995",
                "More Details": "DDI 3"
            }
        ]
    }
}